Medical News

RSS

Positive interim data from Innate MIS416 Phase 1/2 clinical trial for chronic progressive MS

Innate Immunotherapeutics today announced positive interim data from the company's Phase 1/2 clinical trial of MIS416 in patients with chronic progressive multiple sclerosis (MS).

18 Jun 2012

Henry Schein Medical to distribute Alma Lasers' nail fungus treatment

Alma Lasers, Inc. has announced an exclusive distribution arrangement with Henry Schein Medical to launch its latest innovation Harmony ClearChoice – a new, fast, effective approach to nail restoration.

18 Jun 2012

AMA committee fails to find consensus on proposed changes to Medicare

At the annual AMA House of Delegates meeting in Chicago, there was no agreement on whether the doctors' group should endorse a premium-support apporach to Medicare.

18 Jun 2012

Humana, Novo Nordisk enter research partnership to explore diabetes treatment and care

Humana Inc. and Novo Nordisk Inc. today announced a one-year research partnership to explore diabetes treatment and care. Together, researchers will identify opportunities to change how patients might be treated to improve quality and outcomes for the millions of people who battle diabetes.

18 Jun 2012

movin' mania, a community wide effort to address childhood obesity

Bon Secours Virginia Health System has launched movin' mania, a community wide effort to address childhood obesity, the leading health concern for children today. The health system gathered community partners and hundreds of area school children for a kickoff rally Thursday at the Science Museum of Virginia.

18 Jun 2012

Novel strategy for neutralizing unwanted molecules and clearing them from the body

Researchers have unveiled a novel strategy for neutralizing unwanted molecules and clearing them from the body.

18 Jun 2012

Abortion, contraception controversies create political divisions

In some states, even some Republican legislators are not endorsing anti-abortion rules as a group of Catholic hospitals, which had supported the Obama administration's contraception compromise, revoked that approval.

18 Jun 2012

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

Two studies published back-to-back in last week's Nature applied DNA blood testing using the BEAMing technology to detect drug resistance mediated by KRAS mutations in colorectal cancer patients months before treatment failure was observed.

18 Jun 2012

A novel candidate gene in human early-onset degenerative ataxias

Researchers at the University of Helsinki and the Folkh-lsan Research Center, Finland, have identified the genetic cause of early-onset progressive cerebellar degeneration the Finnish Hound dog breed. The study, led by Professor Hannes Lohi, revealed a new disease mechanism in cerebellar degeneration. A mutation was identified in the SEL1L gene, which has no previous link to inherited cerebellar ataxias.

18 Jun 2012

FDA clears St. Jude Medical's AMPLATZER Vascular Plug 4 for transcatheter embolization

St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the AMPLATZER Vascular Plug 4 (AVP 4) for use in transcatheter embolization procedures (minimally invasive procedures that involve the selective blocking of blood vessels) within the peripheral vasculature.

18 Jun 2012

Penumbra adds MAX System of Reperfusion Catheters to family of aspiration thrombectomy devices

The Penumbra System family of aspiration thrombectomy devices now includes the MAX System of Reperfusion Catheters for removal of clots in patients experiencing acute ischemic stroke. The MAX System neuro-interventional devices offer a fast, simplified cerebral thrombectomy procedure with single-operator, over-the-wire delivery without the need for a large proximal balloon guide.

18 Jun 2012

Key health law official leaving post for UnitedHealth VP job

Steve Larsen, director of the federal Center for Consumer Information and Insurance Oversight, is leaving his post to join UnitedHealth as an executive vice president, sparking speculation on the move.

18 Jun 2012

Edluar for insomnia treatment receives regulatory approval in Europe

Orexo AB is pleased to report that Edluar has received regulatory approval in Europe, according to information supplied by Meda AB, Orexo's global commercial partner for the product.

18 Jun 2012

Tips to avoid becoming a mosquito meal

Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.

18 Jun 2012

NGOs have 'critical role' in improving food security

Writing in a commentary on the Center for Strategic & International Studies (CSIS) webpage, Ambassador William Garvelink, a senior adviser with the CSIS Project on U.S. Leadership in Development, and Kristin Wedding, a fellow with the CSIS Global Food Security Project, examine the role of non-governmental organizations (NGOs) in the New Alliance for Food Security and Nutrition, an initiative that "aims to move 50 million people out of poverty over the next decade through agricultural growth and development."

18 Jun 2012

KineMed, GSK enter multi-year biomarker discovery partnership

KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.

18 Jun 2012

FDA grants Cook Pharmica first commercial manufacturing approval

In a decision that paves the way for greater pharmaceutical industry use of the company's contract manufacturing services, Cook Pharmica LLC has received its first approval from the U.S. Food and Drug Administration (FDA) to manufacture commercial product.

18 Jun 2012